Table 2.

Study End-Points by Group

	Global (n=103)	Control (n=51)	Colchicine (n=52)	P value
WHO scale
≥1-grade deterioration	10 (9.7)	7 (13.7)	3 (5.8)	0.303
≥ 2-grade deterioration	2 (1.9)	2 (3.9)	0 (0.0)	0.467
Days to 1-grade improvement	5.36±4.12	4.96±4.71	5.73±3.49	0.350
Change at 14 days	−2.29 (1.01)	−2.24 (1.21)	−2.35 (0.76)	0.579
Change at 28 days	−2.48 (0.96)	−2.35 (1.25)	−2.60 (0.53)	0.199
Adverse events
Death	2 (1.9)	2 (3.9)	0 (0.0)	0.467
ICU admission	6 (5.8)	4 (7.8)	2 (3.8)	0.656
Days in ICU	7.17±6.49	8.25±8.10	5.00±0.00	0.621
Advanced respiratory support	6 (5.8)	4 (7.8)	2 (3.8)	0.656
High outflow oxygen	2 (1.9)	1 (2.0)	1 (1.9)
Non-invasive ventilation	2 (1.9)	1 (2.0)	1 (1.9)
Invasive ventilation	2 (1.9)	2 (3.9)	0 (0.0)
Length of hospitalization	6.18±4.40	5.76±4.89	6.60±3.86	0.340

Abbreviation: ICU, intensive care unit.